Understanding the molecular shift from protective nociception to chronic pathology is essential for answering questions on neuropathic pain and the mechanism of action for several non-opioid medications.

1. Peripheral Sensitization: The “Inflammatory Soup”

Following tissue injury, a cascade of inflammatory mediators is released, lowering the activation threshold of peripheral nociceptors. This is often referred to as the “Inflammatory Soup.”

Key Components:

• Mediators: Histamine, Bradykinin, Prostaglandins, Leukotrienes, Substance P, and Calcitonin Gene-Related Peptide (CGRP).
• Mechanism: These mediators act on the terminal ends of nociceptors, causing them to fire more easily (hyperexcitability).
• Clinical Sign: Primary Hyperalgesia—increased sensitivity to pain occurring at the site of injury.

---

2. Central Sensitization: The “Wind-Up” Phenomenon

Central sensitization refers to an increase in the excitability of neurons within the central nervous system (specifically the dorsal horn). If peripheral nociceptors continue to fire, they “bombard” the second-order neurons, leading to a long-term shift in sensitivity.

The Role of the NMDA Receptor:

In a normal state, the NMDA receptor is blocked by a magnesium (Mg2+) ion.

1. Glutamate Release: Persistent C-fiber stimulation causes a massive release of glutamate.
2. Depolarization: This sustained depolarization eventually dislodges the Mg2+ plug.
3. Calcium Influx: Once the plug is gone, calcium rushes into the cell, triggering a cascade that makes the neuron permanently more sensitive to future stimuli.

Board Pearl: This “Wind-up” is why NMDA antagonists like Ketamine or Memantine are used to treat refractory chronic pain or to prevent opioid-induced hyperalgesia.

---

3. Clinical Manifestations of Sensitization

Board questions often use clinical descriptors to test your understanding of these processes:

• Allodynia: Pain due to a stimulus that does not normally provoke pain (e.g., a light touch or the brush of a bedsheet). This is a hallmark of central sensitization.
• Secondary Hyperalgesia: Increased sensitivity to pain in an area outside the original site of injury. This indicates that the spinal cord, not just the local tissue, has become sensitized.
• Expansion of Receptive Fields: The patient perceives the pain as spreading to wider, non-injured areas.

---

4. Neuro-Glial Interaction

Historically, pain was thought to be strictly neuronal. We now know that Glia (microglia and astrocytes) play a massive role in chronic pain.

• When activated, glia release pro-inflammatory cytokines (like TNF-alpha and IL-beta) that further enhance neuronal excitability.
• This creates a feedback loop that maintains the “sensitized” state even after the original tissue injury has healed.

---

5. Opioid-Induced Hyperalgesia (OIH)

OIH is a paradoxical phenomenon where a patient receiving opioids becomes more sensitive to pain.

• Mechanism: Shared pathways with central sensitization, involving NMDA receptor activation and the up-regulation of Dynorphins.
• Distinguishing from Tolerance: In tolerance, increasing the dose provides more relief. In OIH, increasing the dose makes the pain worse.